Source: Contract Pharma

Auxocell: BioStem Technologies to Acquire Auxocell Labs Assets

Assets provide expertise and resources to enhance manufacturing capabilities for a wide range of regenerative medicine products.

Read full article »
Est. Annual Revenue
$25-100M
Est. Employees
100-250
CEO Avatar

CEO

Update CEO

CEO Approval Rating

- -/100